D McKenzie
Overview
Explore the profile of D McKenzie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
334
Citations
976
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharp D, Sharp D, McKenzie D, McKenzie D, Padayachee L, Padayachee L, et al.
Aust Crit Care
. 2024 Aug;
38(1):101090.
PMID: 39127605
Background: Timely goals-of-care (GOC) discussions are essential for end-of-life planning, particularly during acute hospital admissions, where ambiguity often persists. Frailty, prevalent in the ageing population and linked to adverse outcomes,...
2.
Graby J, Metters R, Kandan S, McKenzie D, Lowe R, Carson K, et al.
Clin Radiol
. 2021 Jul;
76(11):862.e19-862.e28.
PMID: 34261595
Aim: To quantify the real-world clinical and cost impact of computed tomography (CT) coronary angiography (CTCA)-derived fractional flow reserve (FFR) in the National Health Service (NHS). Materials And Methods: Consecutive...
3.
Cullen K, Irvin E, Collie A, Clay F, Gensby U, Jennings P, et al.
J Occup Rehabil
. 2017 Feb;
28(1):1-15.
PMID: 28224415
Purpose The objective of this systematic review was to synthesize evidence on the effectiveness of workplace-based return-to-work (RTW) interventions and work disability management (DM) interventions that assist workers with musculoskeletal...
4.
Alway Y, Gould K, Johnston L, McKenzie D, Ponsford J
Psychol Med
. 2016 Feb;
46(6):1331-41.
PMID: 26867715
Background: Psychiatric disorders commonly emerge during the first year following traumatic brain injury (TBI). However, it is not clear whether these disorders soon remit or persist for long periods post-injury....
5.
Mahmoudi M, Harden S, Abid N, Peebles C, Nicholas Z, Jones T, et al.
Br J Radiol
. 2012 Mar;
85(1016):e461-6.
PMID: 22457316
Objective: The purpose of this study was to assess the outcome of cardiac MRI (CMRI) with late gadolinium enhancement (LGE) at outpatient follow-up in a consecutive series of patients with...
6.
Fenaux P, Mufti G, Hellstrom-Lindberg E, Santini V, Gattermann N, Sanz G, et al.
Ecancermedicalscience
. 2012 Jan;
2:121.
PMID: 22275991
Azacitidine (AZA), as demonstrated in the phase III trial (AZA-001), is the first MDS treatment to significantly prolong overall survival (OS) in higher risk MDS pts ((2007) Blood 110 817)....
7.
Silverman L, Fenaux P, Mufti G, Santini V, Hellstrom-Lindberg E, Gattermann N, et al.
Ecancermedicalscience
. 2012 Jan;
2:118.
PMID: 22275990
The international, phase III, multi-centre AZA-001 trial demonstrated azacitidine (AZA) is the first treatment to significantly extend overall survival (OS) in higher risk myelodysplastic syndromes (MDS) patients (Fenaux (2007) Blood110...
8.
McKenzie D, Hansen J, Becker W
Arch Dis Child
. 2010 Oct;
34(175):250-6.
PMID: 21032358
No abstract available.
9.
10.